← Leaderboards
Chunyang Jin
Research Triangle Institute
$4,561,826
Attributed
$8,511,677
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,511,677 · 7
By mechanism
R01$5,229,853 · 3
R61$1,846,202 · 1
R21$1,215,381 · 2
R03$220,241 · 1
Top collaborators
- Brigitte L Kieffer5 shared
- Joyce Besheer4 shared
- Ann M Decker1 shared
- David Hesk1 shared
- Andrea G Nackley1 shared
Most similar at Research Triangle Institute
Same institution · by research overlap
- John A Kepler$313,742
- F I Carroll$1,285,492
- Elaine Arrington Gay$1,988,072
- David Hesk$110,121
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorG-Protein-Coupled ReceptorsIn VitroIn VivoScaffoldAgonistSmall MoleculeCyclic AmpPharmaceutical PreparationsModificationBrainPharmaceutical ChemistryEvaluationPlayKnockout MiceStructure-Activity RelationshipPropertyDrug KineticsMetabolicChronicBaseLeadNovel TherapeuticsBehavioral Study
Grant awards (14)
Small molecule modulators of RXFP3 for alcohol use disorder$901,666
R01 · FY2025 · AA · contact PI
Development of GPR139 antagonists for the treatment of pain$603,406
R21 · FY2025 · NS · contact PI
Development of Adrb3 Antagonists for the Treatment of Pain$1,846,202
R61 · FY2023 · NS
Small molecule antagonist probes for the relaxin-3/RXFP3 system$677,437
R01 · FY2022 · AA · contact PI
GPR88 Agonist for Alcoholism Treatment$516,567
R01 · FY2022 · AA · contact PI
Small molecule antagonist probes for the relaxin-3/RXFP3 system$635,310
R01 · FY2021 · AA · contact PI
GPR88 Agonist for Alcoholism Treatment$516,567
R01 · FY2021 · AA · contact PI
Small molecule antagonist probes for the relaxin-3/RXFP3 system$594,334
R01 · FY2020 · AA · contact PI
GPR88 Agonist for Alcoholism Treatment$492,682
R01 · FY2020 · AA · contact PI
Preparation and characterization of radioligands for the orphan receptor GPR88$220,241
R03 · FY2020 · AA · contact PI
GPR88 Agonist for Alcoholism Treatment$449,548
R01 · FY2019 · AA · contact PI
GPR88 Agonist for Alcoholism Treatment$445,742
R01 · FY2018 · AA · contact PI
Small molecule probes for the orphan G-protein-coupled receptor GPR88$281,547
R21 · FY2016 · MH · contact PI
Small molecule probes for the orphan G-protein-coupled receptor GPR88$330,428
R21 · FY2015 · MH · contact PI